Bluestar Adisseo Co
SSE:600299
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.77
12.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Bluestar Adisseo Co
Net Income (Common)
Bluestar Adisseo Co
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Bluestar Adisseo Co
SSE:600299
|
Net Income (Common)
ÂĄ1.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-8%
|
|
|
Zhejiang Juhua Co Ltd
SSE:600160
|
Net Income (Common)
ÂĄ4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
144%
|
CAGR 10-Years
36%
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Net Income (Common)
ÂĄ7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
43%
|
|
|
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
|
Net Income (Common)
-ÂĄ751.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
Net Income (Common)
ÂĄ566.2m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
5%
|
CAGR 10-Years
25%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Net Income (Common)
ÂĄ736.3m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Bluestar Adisseo Co
Glance View
In the bustling corridors of the global animal nutrition industry, Bluestar Adisseo Co. stands out as a vital player, shaping the future of sustainable feeding solutions. Born from the amalgamation of Adisseo Group and China National Bluestar Corporation, this company has positioned itself uniquely, bridging Western ingenuity with Eastern scale. The very heart of its operation beats with the synthesis of amino acids, vitamins, and essential enzymes that enhance livestock nutrition. By optimizing feed efficiency, Bluestar Adisseo doesn’t just help farmers yield healthier poultry and livestock; it also plays a critical role in reducing the environmental footprint associated with conventional farming practices. These nutritional supplements are crafted through advanced biotechnology and chemistry, ensuring precision and efficacy, which are the central pillars supporting the company's expansive revenue streams. Bluestar Adisseo’s business model is a testament to its strategic innovation and operational excellence. The company earns its keep through a diversified portfolio that extends across several continents, tapping into various markets through both direct sales and strategic partnerships. By continuously investing in R&D, Adisseo ensures its products align with evolving agricultural needs and regulatory requirements, thus maintaining a competitive edge. Moreover, the company's robust supply chain infrastructure allows for the efficient delivery of high-quality products to farmers globally, safeguarding its market share. It is this mastery over cost-effective production and logistical excellence, coupled with a commitment to sustainability, that keeps Bluestar Adisseo not only relevant but also thriving in the ever-competitive landscape of global animal nutrition.
See Also
What is Bluestar Adisseo Co's Net Income (Common)?
Net Income (Common)
1.2B
CNY
Based on the financial report for Sep 30, 2025, Bluestar Adisseo Co's Net Income (Common) amounts to 1.2B CNY.
What is Bluestar Adisseo Co's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-8%
Over the last year, the Net Income (Common) growth was 9%. The average annual Net Income (Common) growth rates for Bluestar Adisseo Co have been -4% over the past three years , -1% over the past five years , and -8% over the past ten years .